CartiHeal Raises $5M for Agili-CTM, a Single-Stage Arthroscopic Cartilage Regeneration

 
CartiHeal Raises $5 Million in Financing to Support Agili-CTM For Single Stage Arthroscopic Cartilage Regeneration (press release)

CartiHeal  Ltd, a privately held medical device company, focused on developing and bringing to market a proprietary, off-the-shelf, and cell-free cartilage regeneration technology, announced that it raised $5 million in venture funding from two US-Israeli venture capital firms, Accelmed and Access Medical Ventures. The financing will be used to prepare its first product launch early 2013 in Europe.
“Our CE marked Agili-CTM implant represents a true breakt...